Cargando…
Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195268/ https://www.ncbi.nlm.nih.gov/pubmed/25287952 http://dx.doi.org/10.1186/1471-2342-14-34 |
_version_ | 1782339282947538944 |
---|---|
author | Jingu, Akiko Fukuda, Junya Taketomi-Takahashi, Ayako Tsushima, Yoshito |
author_facet | Jingu, Akiko Fukuda, Junya Taketomi-Takahashi, Ayako Tsushima, Yoshito |
author_sort | Jingu, Akiko |
collection | PubMed |
description | BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR). The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol. METHODS: All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs. RESULTS: The protocol was applied to a total of 252 examinations (153 patients, ages 15–87 years; 63 males, 90 females). Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons. There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs. There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate. No patient who had a mild index reaction (IR) had a severe BTR. CONCLUSION: Incidence of BTRs when following the premedication protocol was low. This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma. |
format | Online Article Text |
id | pubmed-4195268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41952682014-10-14 Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol Jingu, Akiko Fukuda, Junya Taketomi-Takahashi, Ayako Tsushima, Yoshito BMC Med Imaging Research Article BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR). The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol. METHODS: All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs. RESULTS: The protocol was applied to a total of 252 examinations (153 patients, ages 15–87 years; 63 males, 90 females). Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons. There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs. There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate. No patient who had a mild index reaction (IR) had a severe BTR. CONCLUSION: Incidence of BTRs when following the premedication protocol was low. This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma. BioMed Central 2014-10-06 /pmc/articles/PMC4195268/ /pubmed/25287952 http://dx.doi.org/10.1186/1471-2342-14-34 Text en Copyright © 2014 Jingu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Jingu, Akiko Fukuda, Junya Taketomi-Takahashi, Ayako Tsushima, Yoshito Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title | Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title_full | Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title_fullStr | Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title_full_unstemmed | Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title_short | Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
title_sort | breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195268/ https://www.ncbi.nlm.nih.gov/pubmed/25287952 http://dx.doi.org/10.1186/1471-2342-14-34 |
work_keys_str_mv | AT jinguakiko breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol AT fukudajunya breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol AT taketomitakahashiayako breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol AT tsushimayoshito breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol |